fulvestrant has been researched along with Animal Mammary Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bénard, F; Langlois, R; Lecomte, R; Ouellet, R; Paquette, M; Phoenix, S; Turcotte, EE; van Lier, JE | 1 |
Greene, GL; Jallow, F; O'Leary, KA; Rugowski, DE; Schuler, LA; Sinkevicius, KW; Sullivan, R | 1 |
Grubbs, CJ; Isayeva, T; Johnson, MD; Kern, FG; Mittal, AR; Ponnazhagan, S; Qu, Z; Ramanathan, HN; Thottassery, JV; Westbrook, L | 1 |
3 other study(ies) available for fulvestrant and Animal Mammary Carcinoma
Article | Year |
---|---|
Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
Topics: Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Estradiol; Female; Fulvestrant; Humans; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Receptors, Estrogen; Tissue Distribution | 2013 |
Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo.
Topics: Aging; Animals; Carcinogenesis; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Mutation; Prolactin; Transforming Growth Factor alpha | 2013 |
High Cks1 expression in transgenic and carcinogen-initiated mammary tumors is not always accompanied by reduction in p27Kip1.
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinogens; Carcinoma; CDC2-CDC28 Kinases; Cyclin-Dependent Kinase Inhibitor p27; Drug Resistance, Neoplasm; Estradiol; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Animal; Methylnitrosourea; Mice; Mice, Transgenic; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tumor Cells, Cultured | 2009 |